InsiderTrades

Form 4 for AORT ARTIVION, INC.

Accepted 2025-12-03 00:00:00 ET · period of report 2025-12-02 · accession 0001628280-25-055181 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-03 2025-12-02 AORT Mackin James P Pres, CEO S - Sale+OE $45.56 -30.9K 801.0K -4% -$1.41M
D 2025-12-03 2025-12-02 AORT Mackin James P Pres, CEO M - OptEx $29.62 +30.9K 831.9K +4% +$915.9K
D 2025-12-03 2025-12-02 AORT Mackin James P Pres, CEO M - OptEx $0.00 -30.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-02 S D 30,921 $45.56 800,993 D — — (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 2, 2025. (F2) Reflects weighted average price. Range of prices were between $45.25 to $46.09. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2025-12-02 M A 30,921 $29.62 831,914 D — — (F1) The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
3 Derivative Stock Options (Right to buy) 2025-12-02 M D 30,921 $0.00 0 D $29.62 · 2020-03-05 to 2026-03-05 30,921 Common Stock (F3) Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.